Company news
Avenir Wellness Solutions Inc. news in 2017
Avenir Wellness Solutions Inc.'s news releases, calls and decks from 2017, newest first.
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
November 7, 2017
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
October 3, 2017
CureDots(TM) Look to Redefine How Animal Clinical Trials Are Conducted -- CFN Media
September 14, 2017
CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal Research
September 6, 2017
CURE Pharmaceutical to Participate in Panel Discussion on the Future of Clinical Research using Cannabis at The Cannabis Science Conference in Portland, OR
August 29, 2017
CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology
August 28, 2017
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
August 22, 2017
CURE Pharma Could Take Over Where Zynerba Fell Short -- CFN Media
August 11, 2017
CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Company’s Proprietary CureFilm™ Into Asian Market
August 10, 2017
Top 4 Companies Reinventing Cannabinoid Delivery -- CFN Media
July 26, 2017
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
July 11, 2017
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
July 11, 2017
CURE Pharma Brings Innovative Drug Delivery to Cannabis & Beyond -- CFN Media
July 7, 2017
CURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery Platform
July 5, 2017
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
June 27, 2017
CURE Pharma Looks to Revolutionize Cannabinoid Delivery
June 15, 2017
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
June 7, 2017
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
May 31, 2017
CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.
May 24, 2017
CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology
May 18, 2017
CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
May 10, 2017
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 9, 2017
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 3, 2017
CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products
March 29, 2017
CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
March 27, 2017
CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board
March 23, 2017
CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.
March 21, 2017
CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
March 16, 2017
Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
March 15, 2017
CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
March 13, 2017
CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies
March 6, 2017
CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board
January 27, 2017
CURE Pharmaceutical Moves to OTCQB Exchange
January 24, 2017